Free Trial

Zotefoams (ZTF) Competitors

Zotefoams logo
GBX 347 -3.00 (-0.86%)
(As of 11/19/2024 ET)

ZTF vs. ESNT, SCPA, SYNT, TET, IOF, WCH, ITX, DCTA, HDD, and BIOM

Should you be buying Zotefoams stock or one of its competitors? The main competitors of Zotefoams include Essentra (ESNT), Scapa Group (SCPA), Synthomer (SYNT), Treatt (TET), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), and Biome Technologies (BIOM). These companies are all part of the "specialty chemicals" industry.

Zotefoams vs.

Zotefoams (LON:ZTF) and Essentra (LON:ESNT) are both small-cap basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

71.7% of Zotefoams shares are held by institutional investors. Comparatively, 121.7% of Essentra shares are held by institutional investors. 19.0% of Zotefoams shares are held by insiders. Comparatively, 1.0% of Essentra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Zotefoams has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Essentra has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500.

Zotefoams has higher earnings, but lower revenue than Essentra.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zotefoams£133.40M1.26£9.93M£0.201,735.00
Essentra£309.70M1.41£5.80MN/AN/A

Zotefoams has a net margin of 7.45% compared to Essentra's net margin of -0.07%. Zotefoams' return on equity of 8.52% beat Essentra's return on equity.

Company Net Margins Return on Equity Return on Assets
Zotefoams7.45% 8.52% 5.48%
Essentra -0.07%0.22%1.74%

Essentra received 116 more outperform votes than Zotefoams when rated by MarketBeat users. Likewise, 72.84% of users gave Essentra an outperform vote while only 69.49% of users gave Zotefoams an outperform vote.

CompanyUnderperformOutperform
ZotefoamsOutperform Votes
246
69.49%
Underperform Votes
108
30.51%
EssentraOutperform Votes
362
72.84%
Underperform Votes
135
27.16%

In the previous week, Zotefoams and Zotefoams both had 1 articles in the media. Zotefoams' average media sentiment score of 1.11 beat Essentra's score of 0.59 indicating that Zotefoams is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zotefoams
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Essentra
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Essentra has a consensus price target of GBX 216.67, suggesting a potential upside of 42.92%. Given Essentra's stronger consensus rating and higher probable upside, analysts clearly believe Essentra is more favorable than Zotefoams.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zotefoams
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Essentra
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Zotefoams pays an annual dividend of GBX 7 per share and has a dividend yield of 2.0%. Essentra pays an annual dividend of GBX 4 per share and has a dividend yield of 2.6%. Zotefoams pays out 3,500.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Essentra beats Zotefoams on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZTF vs. The Competition

MetricZotefoamsSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£168.64M£8.84B£2.84B£1.42B
Dividend Yield1.73%4.02%5.26%11.12%
P/E Ratio1,735.00292.72111.861,572.53
Price / Sales1.26446.41566,834.28214,314.90
Price / Cash18.8718.0223.1333.70
Price / Book1.408.943.682.83
Net Income£9.93M£133.33M£146.58M£157.69M
7 Day Performance-4.67%-1.57%-0.06%3.93%
1 Month Performance-14.11%-7.41%-5.08%2.44%
1 Year Performance9.46%-9.72%29.28%120.33%

Zotefoams Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZTF
Zotefoams
N/AGBX 347
-0.9%
N/A+10.4%£168.64M£133.40M1,735.00549News Coverage
Positive News
ESNT
Essentra
3.0666 of 5 stars
GBX 152
-1.2%
N/A-3.6%£436.45M£309.70M7,980.00350News Coverage
Positive News
SCPA
Scapa Group
N/AGBX 214.50
flat
N/AN/A£402.98M£281.80M-7.321,461
SYNT
Synthomer
2.909 of 5 stars
GBX 171
-1.7%
N/A-6.9%£279.71M£1.97B-280.334,200Gap Up
TET
Treatt
1.5186 of 5 stars
GBX 435.63
-1.0%
N/A-4.0%£264.52M£143.55M2,420.17350Dividend Increase
IOF
Iofina
N/AGBX 19
-2.0%
N/A-26.7%£36.45M£51.71M1,900.0095Gap Down
WCH
Wilmcote Holdings plc (WCH.L)
N/AGBX 3
flat
N/AN/A£20.13MN/A-5.003
ITX
Itaconix
N/AGBX 130
-5.9%
N/A-8.8%£17.54M£6.62M-3,250.0017Gap Down
DCTA
Directa Plus
N/AGBX 9
-7.6%
N/A-75.8%£9.40M£9.33M-150.00187Gap Down
HDD
Hardide
N/AGBX 4.49
+3.2%
N/A-60.5%£3.52M£4.73M-149.6746Gap Up
BIOM
Biome Technologies
N/AGBX 5.06
-3.7%
N/A-95.1%£2.61M£5.75M-14.8727Gap Down

Related Companies and Tools


This page (LON:ZTF) was last updated on 11/19/2024 by MarketBeat.com Staff
From Our Partners